Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,784 INR | -0.52% | +4.10% | +8.00% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-10 | Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.00% | 2.78B | |
-22.13% | 7.9B | |
+76.16% | 4.53B | |
-2.80% | 2.64B | |
-50.41% | 1.99B | |
-19.59% | 1.66B | |
-21.01% | 1.49B | |
+19.31% | 1.23B | |
-45.78% | 1.1B | |
+20.25% | 996M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6%